These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 21320123)
1. Analyses of phenotypic and functional characteristics of CX3CR1-expressing natural killer cells. Hamann I; Unterwalder N; Cardona AE; Meisel C; Zipp F; Ransohoff RM; Infante-Duarte C Immunology; 2011 May; 133(1):62-73. PubMed ID: 21320123 [TBL] [Abstract][Full Text] [Related]
2. The early expansion of anergic NKG2A Roberto A; Di Vito C; Zaghi E; Mazza EMC; Capucetti A; Calvi M; Tentorio P; Zanon V; Sarina B; Mariotti J; Bramanti S; Tenedini E; Tagliafico E; Bicciato S; Santoro A; Roederer M; Marcenaro E; Castagna L; Lugli E; Mavilio D Haematologica; 2018 Aug; 103(8):1390-1402. PubMed ID: 29700172 [TBL] [Abstract][Full Text] [Related]
3. New miRNA Signature Heralds Human NK Cell Subsets at Different Maturation Steps: Involvement of miR-146a-5p in the Regulation of KIR Expression. Pesce S; Squillario M; Greppi M; Loiacono F; Moretta L; Moretta A; Sivori S; Castagnola P; Barla A; Candiani S; Marcenaro E Front Immunol; 2018; 9():2360. PubMed ID: 30374356 [TBL] [Abstract][Full Text] [Related]
4. Evidence for NK cell subsets based on chemokine receptor expression. Berahovich RD; Lai NL; Wei Z; Lanier LL; Schall TJ J Immunol; 2006 Dec; 177(11):7833-40. PubMed ID: 17114454 [TBL] [Abstract][Full Text] [Related]
5. CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK-cell subsets. Yu J; Mao HC; Wei M; Hughes T; Zhang J; Park IK; Liu S; McClory S; Marcucci G; Trotta R; Caligiuri MA Blood; 2010 Jan; 115(2):274-81. PubMed ID: 19897577 [TBL] [Abstract][Full Text] [Related]
6. The biology of human natural killer-cell subsets. Cooper MA; Fehniger TA; Caligiuri MA Trends Immunol; 2001 Nov; 22(11):633-40. PubMed ID: 11698225 [TBL] [Abstract][Full Text] [Related]
7. Natural Killer Cells Generated From Human Induced Pluripotent Stem Cells Mature to CD56 Euchner J; Sprissler J; Cathomen T; Fürst D; Schrezenmeier H; Debatin KM; Schwarz K; Felgentreff K Front Immunol; 2021; 12():640672. PubMed ID: 34017328 [TBL] [Abstract][Full Text] [Related]
9. Co-infection of Cytomegalovirus and Epstein-Barr Virus Diminishes the Frequency of CD56 Lam JKP; Azzi T; Hui KF; Wong AMG; McHugh D; Caduff N; Chan KH; Münz C; Chiang AKS Front Immunol; 2020; 11():1231. PubMed ID: 32625211 [TBL] [Abstract][Full Text] [Related]
10. CD62L expression identifies a unique subset of polyfunctional CD56dim NK cells. Juelke K; Killig M; Luetke-Eversloh M; Parente E; Gruen J; Morandi B; Ferlazzo G; Thiel A; Schmitt-Knosalla I; Romagnani C Blood; 2010 Aug; 116(8):1299-307. PubMed ID: 20505160 [TBL] [Abstract][Full Text] [Related]
11. Natural killer cell subsets and receptor expression in peripheral blood mononuclear cells of a healthy Korean population: Reference range, influence of age and sex, and correlation between NK cell receptors and cytotoxicity. Phan MT; Chun S; Kim SH; Ali AK; Lee SH; Kim S; Kim SH; Cho D Hum Immunol; 2017 Feb; 78(2):103-112. PubMed ID: 27884732 [TBL] [Abstract][Full Text] [Related]
12. Impaired natural killer cell responses are associated with loss of the highly activated NKG2A(+)CD57(+)CD56(dim) subset in HIV-1 subtype D infection in Uganda. Naluyima P; Eller MA; Laeyendecker O; Quinn TC; Serwadda D; Sewankambo NK; Gray RH; Michael NL; Wabwire-Mangen F; Robb ML; Sandberg JK AIDS; 2014 Jun; 28(9):1273-8. PubMed ID: 24959961 [TBL] [Abstract][Full Text] [Related]
13. Killer Ig-like receptor (KIR) genotype predicts the capacity of human KIR-positive CD56dim NK cells to respond to pathogen-associated signals. Korbel DS; Norman PJ; Newman KC; Horowitz A; Gendzekhadze K; Parham P; Riley EM J Immunol; 2009 May; 182(10):6426-34. PubMed ID: 19414796 [TBL] [Abstract][Full Text] [Related]
14. Distinct natural killer cells in HIV-exposed seronegative subjects with effector cytotoxic CD56(dim) and CD56(bright) cells and memory-like CD57⁺NKG2C⁺CD56(dim) cells. Lima JF; Oliveira LM; Pereira NZ; Mitsunari GE; Duarte AJ; Sato MN J Acquir Immune Defic Syndr; 2014 Dec; 67(5):463-71. PubMed ID: 25230289 [TBL] [Abstract][Full Text] [Related]
15. Human natural killer cell maturation defect supports in vivo CD56(bright) to CD56(dim) lineage development. Domaica CI; Fuertes MB; Uriarte I; Girart MV; Sardañons J; Comas DI; Di Giovanni D; Gaillard MI; Bezrodnik L; Zwirner NW PLoS One; 2012; 7(12):e51677. PubMed ID: 23240056 [TBL] [Abstract][Full Text] [Related]
16. Specific phenotype and function of CD56-expressing innate immune cell subsets in human thymus. Gerstner S; Köhler W; Heidkamp G; Purbojo A; Uchida S; Ekici AB; Heger L; Luetke-Eversloh M; Schubert R; Bader P; Klingebiel T; Koehl U; Mackensen A; Romagnani C; Cesnjevar R; Dudziak D; Ullrich E J Leukoc Biol; 2016 Dec; 100(6):1297-1310. PubMed ID: 27354408 [TBL] [Abstract][Full Text] [Related]
17. Proteome analysis of human CD56 Voigt J; Malone DFG; Dias J; Leeansyah E; Björkström NK; Ljunggren HG; Gröbe L; Klawonn F; Heyner M; Sandberg JK; Jänsch L Eur J Immunol; 2018 Sep; 48(9):1456-1469. PubMed ID: 29999523 [TBL] [Abstract][Full Text] [Related]
18. The viral KSHV chemokine vMIP-II inhibits the migration of Naive and activated human NK cells by antagonizing two distinct chemokine receptors. Yamin R; Kaynan NS; Glasner A; Vitenshtein A; Tsukerman P; Bauman Y; Ophir Y; Elias S; Bar-On Y; Gur C; Mandelboim O PLoS Pathog; 2013 Aug; 9(8):e1003568. PubMed ID: 23966863 [TBL] [Abstract][Full Text] [Related]
19. Differential expression of maturation and activation markers on NK cells in patients with active and latent tuberculosis. Albayrak N; Dirix V; Aerts L; Van Praet A; Godefroid A; Dauby N; Windey P; Muylle I; Mascart F; Corbière V J Leukoc Biol; 2022 May; 111(5):1031-1042. PubMed ID: 34889470 [TBL] [Abstract][Full Text] [Related]
20. Human lung natural killer cells are predominantly comprised of highly differentiated hypofunctional CD69 Marquardt N; Kekäläinen E; Chen P; Kvedaraite E; Wilson JN; Ivarsson MA; Mjösberg J; Berglin L; Säfholm J; Manson ML; Adner M; Al-Ameri M; Bergman P; Orre AC; Svensson M; Dahlén B; Dahlén SE; Ljunggren HG; Michaëlsson J J Allergy Clin Immunol; 2017 Apr; 139(4):1321-1330.e4. PubMed ID: 27670241 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]